Parallax Volatility Advisers, L.P. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$1,826,747
-72.7%
44,018
-60.5%
0.00%
-69.2%
Q1 2023$6,699,596
-77.3%
111,400
-72.3%
0.01%
-71.7%
Q4 2022$29,538,045
+89.5%
402,700
+96.3%
0.05%
+91.7%
Q3 2022$15,584,000
+11.8%
205,100
+2.2%
0.02%
+84.6%
Q2 2022$13,942,000
+575.8%
200,600
+705.6%
0.01%
+1200.0%
Q1 2022$2,063,000
-46.1%
24,900
-51.2%
0.00%
-66.7%
Q4 2021$3,829,000
-53.2%
51,000
-27.7%
0.00%
-50.0%
Q3 2021$8,190,000
-52.0%
70,500
-8.4%
0.01%
-60.0%
Q2 2021$17,080,000
-65.8%
77,000
-79.6%
0.02%
-65.1%
Q1 2021$49,988,000
-35.0%
378,187
-14.9%
0.04%
-24.6%
Q4 2020$76,901,000
+292.5%
444,398
+152.4%
0.06%
+280.0%
Q3 2020$19,594,000
+135.3%
176,051
+25.6%
0.02%
+50.0%
Q2 2020$8,326,000
-45.9%
140,204
-38.6%
0.01%
-50.0%
Q1 2020$15,378,000
+14830.1%
228,375
+7293.2%
0.02%
Q4 2018$103,000
-95.2%
3,089
-95.5%
0.00%
-100.0%
Q2 2018$2,160,000
+608.2%
69,020
+393.0%
0.00%
Q1 2018$305,000
-84.0%
14,000
-85.2%
0.00%
-100.0%
Q4 2017$1,912,000
-0.6%
94,678
-2.3%
0.00%
-33.3%
Q3 2017$1,923,000
+344.1%
96,900
+287.6%
0.00%
+200.0%
Q2 2017$433,000
+113.3%
25,0000.0%0.00%
Q1 2017$203,000
-4.7%
25,0000.0%0.00%
Q3 2016$213,000
-27.1%
25,0000.0%0.00%
-100.0%
Q2 2016$292,00025,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders